FDAnews
www.fdanews.com/articles/97850-zydus-cadila-files-its-5th-ind-lsquo-zyh7-rsquo

Zydus Cadila Files Its 5th IND ‘ZYH7’

August 30, 2007

Continuing with its successful research programme, Zydus Cadila has filed yet another IND (Investigational New Drug) application for seeking DCGI’s permission for conducting clinical trials for its New Molecular Entity (NME) — ZYH7, a novel drug candidate for treating dyslipidemia and metabolic disorders.
Zydus Cadila